About Us

Brian Hurley, MD, MBA, DFASAM

0:00 / 0:00

Candidate for President-Elect

Biography and Statement

Brian Hurley, MD, MBA, DFASAM

1. What are your greatest contributions to ASAM and the field of addiction medicine?

  1. Amplifying ASAM's impact – As your Treasurer from 2015-2019, I was privileged to guide ASAM's financial governance during a period of unprecedented growth from a $5M to nearly $10M annual budget and net assets of $5M to over $12M, with an operating reserve of over 50% of the annual budget. This reflects an extraordinary increase in ASAM’s membership and in the size of ASAM’s staff to support ASAM’s mission to advance addiction medicine. Supported by our financial management, we’ve seen the deployment of new major ASAM educational initiatives, key national policy achievements achieved by ASAM, and greater recognition of addiction medicine as a core component of general medical practice than at any other point in our history. I am proud to have supported our financial growth in service to ASAM’s mission.
  2. ASAM's Executive Transitions - I served on the EVP/CEO Search committees that selected ASAM's prior EVP/CEO, Penny Mills, and current EVP/CEO Julia Chang. Penny did a tremendous job of growing ASAM into a mature major medical association. Participating in Penny's selection and onboarding have been my most enduring contribution to ASAM prior to 2020. I was additionally privileged to have served on the EVP/CEO Search committee that selected Julia Chang. Executive transitions are critical inflection points of ASAM, and I’m proud to have shaped ASAM’s executive leadership as a contributor to these search committees.
  3. ASAM’s Internal Policy Development – I have helped lead internal initiatives as a member of ASAM’s governance to help resolve key areas of organizational ambivalence. In 2013, as the Chair of ASAM’s Membership Committee, I led the discussion of the ASAM Board of Directors which led to the adoption of internal policy to establish an Associate Membership category for nonphysicians. More recently, in 2018-2019, I chaired ASAM’s External Support Task Force who’s work led ASAM’s Board of Director to update our policy on the appropriateness of corporate support and ultimately sunset the ASAM Corporate Roundtable. Finally, also in 2019, I led ASAM’s Task Force on the Mainstreaming Addiction Treatment Act which culminated in ASAM’s support of eliminating the DATA-2000 buprenorphine waiver requirement contingent upon mandatory education in controlled substance prescribing for all DEA certificate holders.
  4. Addiction Medicine as a core medical specialty– As the Director of Addiction Medicine for Los Angeles County’s Department of Health Services, I advance the delivery of addiction medicine treatments in primary care clinics, community mental health centers, the Los Angeles County jail, and the four major hospital centers operated by Los Angeles County. I am a co-investigator on a series of implementation science projects that build tools that facilitate public-sector programs integrating addiction treatment into community health services. To this end, I am a co-primary investigator on a California Tobacco Related Disease Research Program-funded implementation project to establish smoking cessation services in Los Angeles’ primary care and community mental health clinics. I am the lead author on a RAND Corporation publication providing guidance on the use of medications for alcohol use disorder in community mental health settings. I have worked on onboard substance abuse counselors and social workers to provide integrated behavioral health treatment for patients empaneled to LA County-operated patient centered medical homes. Additionally, I have provided waiver trainings to over 600 individuals who work in public sector settings in California with the aim to establish addiction medicine as a service that can be delivered in any setting of care. This work is squarely resonant with ASAM's mission to solidify addiction medicine's position as a core medical specialty and magnifies the penetrance of quality addiction services to patients with addiction.

2. How would your election benefit ASAM and the field of addiction medicine?

  1. Action Oriented Governance – ASAM’s successful execution of our ambitious strategic plan necessitates close collaboration between board leadership, ASAM’s new EVP/CEO (Julia Chang), our growing number of staff, and ASAM’s expanding partnerships and constituencies. If elected as President-elect, I offer an experienced hand to facilitate board decision making that combines the capability of our executives with the wisdom and direction of governance. My background as a Director at Large, former treasurer, and as a long-time member of association governance within ASAM, as well as my previous experience as a board member of the American Psychiatric Association and Gay and Lesbian Medical Association, and as the former National President and chairman of the American Medical Student Association, has prepared me well to serve as your chief elected official. Maintaining a strong professional society is essential for our field. Having served ASAM during this transformative era for addiction medicine, I pledge to advance ASAM’s ongoing success.
  2. Coalition Building – ASAM is the leading medical society in the addiction field; a field that faces the ever-growing involvement of federal, state, and local governmental agencies, payers, health care delivery organizations, academic institutions, advocacy groups, industry players, other medical associations, and the variety of physicians working with patients with addiction. ASAM is in the key position to convene broad stakeholders toward a shared focus on remission and recovery from the disease of addiction. Growing the capacity of our field requires building a coalition that thrives despite dissonance, and the breadth of my professional background and depth of work in areas historically resistant to involvement by addiction physicians is a testament to my capacity to bridge historic differences and assemble a wide coalition resonant with ASAM’s mission. A future when addiction prevention, treatment, remission and recovery are accessible to all requires no less ambitious an effort.

Biographical Sketch

Brian Hurley, MD, MBA, DFASAM is an addiction physician, a Director at Large on the ASAM Board of Directors, the Director of Addiction Medicine for Los Angeles County’s Department of Health Services (LACDHS), and Volunteer Assistant Clinical Professor of Addiction Medicine at the UCLA Department of Family Medicine. In Los Angeles County, he launched the LACDHS Addiction Medicine Consultation telephone service, directed the integration of addiction counseling and support services into LACDHS ambulatory care clinics, and implements medications for addiction treatment services within LACDHS hospitals, specialty clinics, and primary care practices. He also provides direct psychiatric services to patients in the Los Angeles County Jail, which, with over 17,000 inmates, is the largest mental health institution in the United States.

He is board certified by ABAM and the ABPM in addiction medicine and by the ABPN in psychiatry and addiction psychiatry. He joined ASAM in 2002 as a first year medical student and has served on the ASAM Board of Directors in various capacities since 2003. He served as the co-chair of ASAM's Membership Committee from 2008-2015 and spent two years as a member of ASAM’s finance committee before being twice elected ASAM’s Treasure (in 2015 and 2017) where be chaired this committee and served on ASAM’s Executive Committee. In 2018-2019 Brian led ASAM’s External Support Task Force which generated recommendations for the ASAM Board of Directors that resulted in ASAM’s sunsetting our Corporate Roundtable. Since 2004, he has also periodically served as ASAM’s alternate delegate to the American Medical Association. Prior to 2008, Brian served as chair of ASAM’s Physicians-in-Training Committee. Brian additionally served on ASAM’s EVP/CEO search committees in 2010 and 2020 that led to Penny Mills’ and Julia Chang’s selections (respectively) as ASAM’s EVP/CEO. He has additional served the Massachusetts Society of Addiction Medicine as the education chair where he supported the launch of MASAM’s Addiction Medicine for All Providers conference, which has become a seminal annual event for ASAM’s MA chapter. He has also served in various roles for the California Society of Addiction Medicine including chairing the CSAM Committee on Integration and Access to System of Care subcommittee addressing Other Systems of Care, serving on the CSAM Task Force on Marijuana Policy, and serving on various education planning committees. He served on CSAM’s Executive Director Search Committee in 2019-2020 support CSAM’s most recent executive transition.

He co-chairs the Los Angeles County Department of Health Services’ Substance Use Disorders Workgroup and the SafeMedLA Medications for Addiction Treatment Action Team, and is the Clinical Director of the Addiction Treatment Starts Here programs through the Center for Care Innovations, focused on increasing the delivery of Medications for Addiction Treatment in California’s community health centers. He is the PI of three MAT Access Points projects funded by the Sierra Health Foundation, a co-PI of a TRDRP funded smoking cessation implementation project, and a co-investigator on NIDA, NIAAA, and PCORI funded addiction related implementation science grants managed through RAND. He is a member of the Motivational Interviewing Network of Trainers and regularly conducts motivational interviewing trainings throughout the United States. He additionally serves on the American Board of Psychiatry and Neurology’s Addiction Psychiatry examination writing committee.

Brian completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California, Los Angeles (UCLA), and was previously a UCLA - Veterans Administration National Quality Scholar at the VA Greater Los Angeles Healthcare System. He completed a clinical fellowship program in addiction psychiatry at New York University School of Medicine and residency training at the Massachusetts General Hospital and McLean Hospital (MGH-McLean), where he was Chief Resident in Addiction Psychiatry. Brian is a graduate of the Keck School of Medicine and Marshall School of Business of the University of Southern California with both M.D. and M.B.A. degrees. Brian is a former National President and Director of Student Programming for the American Medical Student Association; roles through which Brian has been an invited speaker at medical schools throughout the world addressing topics ranging from global health equity, healthcare reform, pharmaceutical advertising and ethics, lesbian gay bisexual and transgender equality, and medical student wellness. Brian previously served on the American Medical Colleges’ Lesbian, Gay, Bisexual, Transgender and Differences of Sexual Development Patient Care Advisory Committee, was the Gay and Lesbian Medical Association's delegate to the American Medical Association's (AMA's) House of Delegates, and served on the Board of Trustees of the American Psychiatric Association (APA) during a period of significant organizational transition including the release of DSM-5 and the selection of new APA Medical Director / CEO Saul Levin, M.D. Brian dedicates his career demonstrating the transformative impact addiction medicine has when integrated throughout healthcare.